卟吩姆钠治疗肿瘤的临床研究进展

Clinical research progress of porfimer sodium for cancer treatment

光动力疗法(PDT)因其不良反应低、具有选择性等优势逐步成为临床肿瘤治疗的重要疗法。卟吩姆钠(porfimer sodium,Photofrin)是首个获批的光动力药物,在膀胱癌、肺癌和宫颈癌等方面的疗效引起关注,本文主要综述卟吩姆钠-PDT用于临床肿瘤治疗的研究进展。

Due to less side effects and higher selectivity, the photodynamic therapy（PDT） gradually becomes an important treatment of cancer. The porfimer sodium（Photofrin） is the first approved photodynamic drug in bladder cancer, lung cancer and cervical cancer so on. This article reviews the clinical progress of porfimer sodium-PDT in cancer treatment.